Ascites

R18_ASCITES

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R18 Cause of death: ICD-10 — R18 2 out of 7 registries used, show all original rules.	2786
4. Check minimum number of events None	2786
5. Include endpoints None	2786
6. Filter based on genotype QC (FinnGen only)	2786

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_DIGES_SYSTEM_ABDOMEN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R1
Name in latin: Ascites

NAME	R18_ASCITES
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_DIGES_SYSTEM_ABDOMEN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R18
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R18
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ascites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2786	1503	1283
Unadjusted period prevalence (%)	0.54	0.51	0.57
Median age at first event (years)	67.21	67.22	67.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2445: Matched controls
24450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R18

ICD-10 Finland

Ascites

4503599627370496.0

323.0

2439

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

198.6

323.0

427

Z51.5

ICD-10 Finland

Palliative care

13.2

323.0

638

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

10.2

323.0

867

1249

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

222.9

323.0

808

C03DA01

ATC

spironolactone; oral

14.8

323.0

1134

1345

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

77.8

323.0

431

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

6.0

323.0

1193

3356

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

84.5

323.0

505

C03CA01

ATC

furosemide; systemic

5.9

323.0

1422

4639

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

10.6

323.0

916

1306

A03FA01

ATC

metoclopramide; systemic, rectal

5.9

289.1

1016

2644

N02AA05

ATC

oxycodone; systemic

6.7

286.6

858

1815

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

101.3

276.7

302

128

Kela drug reimbursment

Cancers of female genital organs

37.7

265.3

342

105

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

13.6

246.7

450

398

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

85.6

240.4

268

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

14.0

230.7

414

350

A06AD11

ATC

lactulose; oral

5.9

229.2

752

1715

H02AB02

ATC

dexamethasone; systemic

6.4

221.4

667

1358

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

8.3

211.4

512

757

TJA10

NOMESCO Finland

Laparocentesis

1086.7

207.3

200

A04AA01

ATC

ondansetron; systemic, rectal

8.7

203.9

477

664

JN3BD

NOMESCO Finland

Extensive abdominal CT

7.6

201.6

520

842

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

64.6

197.1

229

JAL30

NOMESCO Finland

Omentectomy

51.1

195.2

236

130

Kela drug reimbursment

Malignant tumour

6.6

185.4

533

996

JN4BD

NOMESCO Finland

Extensive body CT

5.5

182.4

619

1420

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

159.6

1404

7252

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

127.1

155.2

166

JN3AD

NOMESCO Finland

Abdominal CT examination

7.8

149.4

370

547

A02BC02

ATC

pantoprazole; systemic

3.2

148.7

1800

11356

WW500

NOMESCO Finland

Blood transfusion

9.7

146.8

314

364

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

82.1

143.3

161

K70.4

ICD-10 Finland

Alcoholic hepatic failure

96.6

139.9

154

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.0

139.3

509

1231

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

17.5

133.2

215

134

B01AB10

ATC

tinzaparin; parenteral

5.9

131.7

405

799

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

10.1

130.9

273

300

A04AA02

ATC

granisetron; systemic, transdermal

6.4

129.4

368

656

R11

ICD-10 Finland

Nausea and vomiting

11.8

128.6

247

231

JAH01

NOMESCO Finland

Laparoscopy

12.1

126.1

239

217

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

639.5

124.4

122

ZX120

NOMESCO Finland

Intravenous

4.8

122.7

459

1125

WX302

NOMESCO Finland

Thoracal epidural anesthesy

7.4

122.5

312

475

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

134.9

120.3

128

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.3

115.9

332

593

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

157.6

114.3

120

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.8

114.0

228

230

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

113.1

607

2055

TPH04

NOMESCO Finland

Cathetrisation of vein

3.2

110.6

719

2810

R10.1

ICD-10 Finland

Pain localized to upper abdomen

5.2

109.8

370

803

JN4AD

NOMESCO Finland

Body CT examination

5.1

109.7

384

869

C56

ICD-10 Finland

Malignant neoplasm of ovary

73.0

109.6

125

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

8.3

107.7

251

331

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

221.4

103.4

106

UJF32

NOMESCO Finland

Coloscopy

3.0

101.7

747

3144

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

8.9

100.4

224

274

L01BC06

ATC

capecitabine; oral

7.6

99.6

246

354

TPH07

NOMESCO Finland

Cathetrisation of artery

4.0

97.8

445

1294

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.6

97.8

979

4958

K70.1

ICD-10 Finland

Alcoholic hepatitis

53.3

97.7

117

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

72.5

97.3

111

B01AB05

ATC

enoxaparin; parenteral

2.6

96.6

978

4975

D64.9

ICD-10 Finland

Anaemia, unspecified

3.9

95.0

435

1270

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

11.2

92.7

181

173

L03AA13

ATC

pegfilgrastim; parenteral

6.8

92.6

248

400

K92.0

ICD-10 Finland

Haematemesis

11.8

92.3

176

160

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

8.4

91.7

211

271

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.1

90.6

199

236

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

51.2

89.6

108

A07AA11

ATC

rifaximin; oral

442.8

86.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

7.9

86.5

208

286

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

10.6

86.2

173

174

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

5.0

85.9

298

659

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

7.3

84.5

214

318

JAH00

NOMESCO Finland

Laparotomy

11.6

83.7

160

146

JAL00

NOMESCO Finland

Biopsy of peritoneum

46.3

79.9

K72.9

ICD-10 Finland

Hepatic failure, unspecified

51.9

79.1

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

21.9

79.0

117

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

10.2

77.6

159

166

J94.8

ICD-10 Finland

Other specified pleural conditions

12.0

77.0

145

128

N02AX02

ATC

tramadol; systemic, rectal

2.3

76.3

1118

6641

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.1

73.3

210

368

JEA00

NOMESCO Finland

Appendectomy

5.9

72.9

215

391

K76.7

ICD-10 Finland

Hepatorenal syndrome

254.1

72.7

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

193.3

72.5

Z94.4

ICD-10 Finland

Liver transplant status

82.7

71.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.8

71.4

329

950

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

69.6

70.7

I50.9

ICD-10 Finland

Heart failure, unspecified

3.0

70.4

479

1856

C07AA05

ATC

propranolol; systemic

2.8

70.0

533

2215

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.6

69.7

260

615

I50.0

ICD-10 Finland

Congestive heart failure

4.0

69.6

306

847

R50.9

ICD-10 Finland

Fever, unspecified

3.1

68.7

427

1553

JN4CD

NOMESCO Finland

Very extensive body CT

5.7

67.4

204

382

JJC00

NOMESCO Finland

Allogenic transplantation of liver

107.4

67.2

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4.8

66.5

236

530

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

8.8

66.4

147

176

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

4.1

65.2

274

726

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.7

64.7

312

933

LCD00

NOMESCO Finland

Hysterectomy

5.1

64.3

215

452

K92.1

ICD-10 Finland

Melaena

4.9

63.7

223

493

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

9.7

62.6

131

142

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.2

62.4

369

1289

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.5

62.0

561

2556

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

66.4

61.6

WX892

NOMESCO Finland

Monitored bed care

3.7

61.2

292

863

D25

ICPC

Abdominal distension

11.0

61.0

119

113

L03AA14

ATC

lipegfilgrastim; parenteral

8.7

59.8

133

160

J01MA02

ATC

ciprofloxacin; systemic

2.1

59.5

1002

6116

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

13.3

59.0

105

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

58.1

485

2104

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

13.4

58.0

103

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

56.8

706

3751

K72.1

ICD-10 Finland

Chronic hepatic failure

122.9

56.0

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

+∞

55.4

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

36.5

55.3

D97

ICPC

Liver disease NOS

30.5

55.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

54.2

267

807

UJK02

NOMESCO Finland

ERCP

9.4

53.9

114

126

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

19.0

53.8

127

Kela drug reimbursment

Transplant complication

10.5

53.7

107

106

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.2

53.5

175

358

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

44.4

52.8

L03AA02

ATC

filgrastim; parenteral

6.5

52.8

142

228

TK800

NOMESCO Finland

Hemodialysis

7.6

52.3

127

176

A04AA55

ATC

palonosetron, combinations; systemic

5.9

52.1

152

271

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

14.9

52.1

N05CF01

ATC

zopiclone; oral

2.0

51.8

854

5086

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

51.7

682

3697

K65.0

ICD-10 Finland

Acute peritonitis

14.2

51.0

J01MA12

ATC

levofloxacin; systemic

2.4

51.0

502

2363

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.6

50.6

135

214

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.7

50.3

181

410

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

10.4

49.9

100

L04AA06

ATC

mycophenolic acid; systemic

9.0

49.5

107

123

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.0

49.3

208

549

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

255.1

49.2

A10AE04

ATC

insulin glargine; parenteral

3.0

49.0

312

1136

A09AA02

ATC

multienzymes (lipase, protease etc.)

10.6

49.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

8.9

48.2

105

122

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

11.8

47.5

A41.9

ICD-10 Finland

Sepsis, unspecified

5.2

47.3

155

317

WZC30

NOMESCO Finland

Teaching

2.5

47.3

411

1803

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

15.8

47.3

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

166.5

47.0

A06AH03

ATC

naloxegol; oral

13.4

46.5

R4190

NOMESCO Finland

Nutritional therapy

6.0

46.2

133

233

X77

ICPC

Malignant neopl genital female other

41.7

45.8

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.6

45.8

224

671

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

46.8

45.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

44.9

241

775

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.3

44.6

142

281

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

7.2

44.3

111

161

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

11.9

44.0

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

6.6

43.8

117

186

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.5

43.8

118

190

K83.1

ICD-10 Finland

Obstruction of bile duct

12.5

43.5

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

7.0

43.3

110

163

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

43.3

745

4444

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

43.0

463

2259

B03XA02

ATC

darbepoetin alfa; parenteral

7.0

42.8

109

162

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

17.6

42.5

R10.0

ICD-10 Finland

Acute abdomen

13.9

42.1

K70.0

ICD-10 Finland

Alcoholic fatty liver

17.8

42.0

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

55.5

41.5

P15

ICPC

Chronic alcohol abuse

6.4

41.1

111

179

M04AA01

ATC

allopurinol; systemic

2.4

41.0

396

1829

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

145.8

40.9

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

33.8

40.8

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

10.3

40.5

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

33.2

39.8

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

+∞

39.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

13.1

39.4

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.4

39.1

148

352

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

8.9

39.1

A28

ICPC

Limited function/disability NOS

2.2

38.9

436

2158

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

138.9

38.8

SPAT1262

SPAT

Handing over of treatment supplies

2.1

38.8

510

2711

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

5.8

38.7

114

206

R4110

NOMESCO Finland

Physiotherapy

1.9

38.1

698

4221

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

37.8

235

836

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.5

37.5

188

572

I81

ICD-10 Finland

Portal vein thrombosis

30.0

37.4

E87.5

ICD-10 Finland

Hyperkalaemia

7.6

37.2

121

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

18.5

36.2

WX402

NOMESCO Finland

General anaesthesia

2.2

35.9

420

2111

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.5

35.6

151

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.5

35.5

108

203

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

13.5

35.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

35.2

430

2201

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.3

35.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

9.8

34.8

K83.0

ICD-10 Finland

Cholangitis

11.7

34.8

K29.6

ICD-10 Finland

Other gastritis

10.9

34.7

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

34.6

491

2676

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

34.4

290

1238

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.0

33.9

140

362

N19

ICD-10 Finland

Unspecified kidney failure

4.2

33.7

133

330

3009

Kela drug reimbursment

Niraparib

331.3

33.0

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.7

32.8

150

424

V03AE01

ATC

polystyrene sulfonate; oral

8.6

32.7

I50.1

ICD-10 Finland

Left ventricular failure

3.4

32.6

164

501

C07AG02

ATC

carvedilol; oral

2.9

32.5

212

778

A46

ICD-10 Finland

Erysipelas

2.2

32.4

389

1972

A98

ICPC

Health maint/preventive medicine

0.5

32.3

1882

21131

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.9

32.2

K76.9

ICD-10 Finland

Liver disease, unspecified

7.9

32.2

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

6.4

32.1

138

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

11.6

32.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

32.0

175

569

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

14.5

32.0

K56.7

ICD-10 Finland

Ileus, unspecified

8.6

31.9

R53

ICD-10 Finland

Malaise and fatigue

2.0

31.9

451

2446

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

7.6

31.9

103

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

8.5

31.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.7

31.5

169

J01DB01

ATC

cefalexin; oral

1.8

31.4

1859

15744

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

39.6

31.2

D01

ICPC

Abdominal pain/cramps general

2.9

31.1

207

767

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

25.7

31.0

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.3

30.7

135

N17.8

ICD-10 Finland

Other acute renal failure

9.1

30.6

WX002

NOMESCO Finland

Sedation and analgesia

1.9

30.6

507

2919

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

38.6

30.3

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

12.5

30.0

1XC07

NOMESCO Finland

33.0

30.0

R06.0

ICD-10 Finland

Dyspnoea

1.8

29.9

579

3523

1510

Kela drug reimbursment

Niraparib

306.0

29.9

N05BA04

ATC

oxazepam; oral

1.9

29.3

547

3281

K65.8

ICD-10 Finland

Other peritonitis

66.8

28.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.6

28.9

119

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

9.7

28.9

JJ5AT

NOMESCO Finland

295.2

28.8

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

28.8

218

872

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

28.5

561

3420

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

8.9

28.5

L04AD01

ATC

ciclosporin; systemic

5.7

28.4

149

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

17.0

28.4

UJD02

NOMESCO Finland

Gastroscopy

3.9

28.3

121

323

E87.6

ICD-10 Finland

Hypokalaemia

4.3

28.3

108

260

C574, 8461, 3

ICD-O-3

+∞

28.2

JMA10

NOMESCO Finland

Transabdominal total splenectomy

16.3

28.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

28.0

317

1559

K76.6

ICD-10 Finland

Portal hypertension

78.5

27.8

8461/3-C48.2

ICD-O-3

High grade serous carcinoma of peritoneum, NOS

284.6

27.8

G93.4

ICD-10 Finland

Encephalopathy, unspecified

43.0

27.7

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.2

27.7

175

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

27.7

202

792

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

17.5

27.5

R60.0

ICD-10 Finland

Localized oedema

2.2

27.5

303

1472

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.9

27.2

103

R13

ICD-10 Finland

Dysphagia

5.1

27.1

175

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

62.7

27.0

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

27.0

169

601

M10.9

ICD-10 Finland

Gout, unspecified

2.7

26.7

196

770

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

26.4

614

3937

B18.2

ICD-10 Finland

Chronic viral hepatitis C

11.9

26.2

L01XK02

ATC

niraparib; oral

+∞

26.1

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

60.7

26.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

25.9

479

2850

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

40.5

25.8

N18.8

ICD-10 Finland

Other chronic renal failure

4.3

25.8

230

K65.9

ICD-10 Finland

Peritonitis, unspecified

33.4

25.6

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

6.0

25.4

121

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

25.3

144

481

WX872

NOMESCO Finland

Intensive care

2.9

25.2

159

569

JFB00

NOMESCO Finland

Partial resection of small intestine

8.3

25.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.8

25.1

127

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.8

25.1

186

SPAT1122

SPAT

Ascites puncture

+∞

25.0

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.6

24.8

117

340

C48.00

ICD-10 Finland

Malignant tumor of the retroperitoneal space without histology

252.6

24.7

A10BA02

ATC

metformin; oral

1.7

24.6

700

4746

H02AB06

ATC

prednisolone; systemic

1.6

24.5

1032

7745

B01AB04

ATC

dalteparin; parenteral

3.0

24.1

146

510

T90

ICPC

Diabetes non-insulin dependent

1.7

23.9

579

3739

A41.8

ICD-10 Finland

Other specified sepsis

5.5

23.9

135

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

23.8

161

603

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

9.1

23.8

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

8.2

23.7

L02BA03

ATC

fulvestrant; parenteral

10.9

23.6

SPAT1255

SPAT

Intravenous administration of medicine

2.6

23.5

177

705

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

23.5

199

848

A04AD12

ATC

aprepitant; systemic

4.8

23.5

168

A02BC01

ATC

omeprazole; systemic

1.7

23.4

590

3850

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

23.3

138

473

A79

ICPC

Malignancy NOS

6.8

23.2

B01AA03

ATC

warfarin; systemic

1.8

23.0

506

3171

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

22.5

513

3246

A05AA02

ATC

ursodeoxycholic acid; oral

6.2

22.4

101

A10AE05

ATC

insulin detemir; parenteral

2.8

22.4

152

570

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

24.1

22.2

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

21.6

22.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

6.0

22.1

103

P01AB01

ATC

metronidazole; oral, rectal

1.6

22.1

779

5556

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

21.9

245

1194

TJA00

NOMESCO Finland

Puncture of peritoneum

+∞

21.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.4

21.9

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

13.9

21.8

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

25.3

21.7

D70.82

ICD-10 Finland

Drug-induced neutropenia

5.0

21.3

141

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

9.7

21.3

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

19.0

21.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

7.2

21.1

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

21.0

163

662

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

20.9

787

5682

L02BG04

ATC

letrozole; oral

2.4

20.9

180

774

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

20.8

127

446

SPAT1269

SPAT

Other puncture and/or drainage

9.3

20.8

RS220

NOMESCO Finland

7.4

20.7

1511

Kela drug reimbursment

Olaparib

211.6

20.6

192

Kela drug reimbursment

Fulvestrant

10.4

20.6

K29.2

ICD-10 Finland

Alcoholic gastritis

30.3

20.6

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

12.1

20.5

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

11.3

20.4

AA1AD

NOMESCO Finland

CT of head and brain

1.7

20.4

536

3522

A10BB12

ATC

glimepiride; oral

2.3

20.4

198

902

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

7.1

20.4

A10BH01

ATC

sitagliptin; oral

2.1

20.4

253

1287

F10.24

ICD-10 Finland

Alcohol depence active use

7.2

20.3

N07BB01

ATC

disulfiram; oral

3.1

19.9

111

367

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

19.7

284

1533

JCA20

NOMESCO Finland

Ligature of oesophageal varices

74.1

19.7

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.2

19.6

215

1038

SPAT1254

SPAT

Administration of medicine

1.9

19.6

318

1792

389

Kela drug reimbursment

Olaparib

201.5

19.6

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3.0

19.4

114

391

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.2

19.4

117

N06AX11

ATC

mirtazapine; oral

1.6

19.2

640

4466

A10BH05

ATC

linagliptin; oral

2.6

19.2

145

580

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

7.5

19.2

3AC01

NOMESCO Finland

6.4

19.1

E86

ICD-10 Finland

Volume depletion

4.1

19.1

187

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.6

19.1

140

550

I50

ICD-10 Finland

Heart failure

3.2

19.1

102

328

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.7

18.9

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

34.6

18.9

J01FF01

ATC

clindamycin; systemic

1.6

18.9

577

3938

B03XA01

ATC

erythropoietin; parenteral

8.8

18.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

18.9

556

3760

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

18.9

209

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.6

18.7

142

570

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

18.7

253

1333

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

18.6

323

1865

JFB30

NOMESCO Finland

Right hemicolectomy

5.6

18.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

9.2

18.4

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

9.6

18.4

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

25.2

18.2

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

6.9

18.2

C07AB07

ATC

bisoprolol; oral

1.5

18.2

1103

8776

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

52.9

18.0

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

10.8

17.9

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

5.1

17.9

111

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

8.0

17.8

A40.8

ICD-10 Finland

Other streptococcal sepsis

8.0

17.8

SPAT1125

SPAT

Stoma care and guidance

5.1

17.8

112

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

13.8

17.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

17.7

232

1206

D77

ICPC

Malignant digestive neopl other/NOS

12.5

17.6

R60.1

ICD-10 Finland

Generalized oedema

12.5

17.6

TGA30

NOMESCO Finland

Thoracocentesis

6.9

17.4

369

Kela drug reimbursment

Regorafenib

29.0

17.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.8

17.4

194

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.4

17.3

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

18.7

17.3

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

21.0

17.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

17.3

178

3173

A02BC05

ATC

esomeprazole; systemic

1.5

17.1

794

5950

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

16.0

17.0

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.2

17.0

288

198

Kela drug reimbursment

Sorafenib

13.3

16.9

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.5

16.9

240

1501

Kela drug reimbursment

Palbociclib

8.7

16.9

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.6

16.9

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

22.0

16.8

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

16.8

167

770

WX882

NOMESCO Finland

High dependency care

3.4

16.8

247

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

10.4

16.7

K74.0

ICD-10 Finland

Hepatic fibrosis

35.3

16.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

16.7

142

608

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

16.4

16.5

K70

ICD-10 Finland

Alcoholic liver disease

171.1

16.5

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

27.7

16.5

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

6.0

16.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

16.5

124

495

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

16.4

282

1618

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

16.4

100

351

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

16.4

128

523

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

16.4

334

2028

JFB46

NOMESCO Finland

Resection of sigmoid colon

5.9

16.3

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.5

16.3

Z94.0

ICD-10 Finland

Kidney transplant status

6.7

16.3

TK810

NOMESCO Finland

Hemofiltration

8.1

16.3

K86.1

ICD-10 Finland

Other chronic pancreatitis

12.9

16.1

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.4

16.1

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

47.8

16.0

K29.7

ICD-10 Finland

Gastritis, unspecified

3.1

16.0

290

B82

ICPC

Anaemia other/unspecified

3.6

15.7

202

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4.0

15.7

157

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

15.7

200

1030

K76.1

ICD-10 Finland

Chronic passive congestion of liver

85.6

15.6

L01BC59

ATC

trifluridine, combinations; systemic

22.2

15.5

176

Kela drug reimbursment

Regorafenib

22.2

15.5

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

15.5

319

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.6

15.5

115

456

I86.4

ICD-10 Finland

Gastric varices

160.9

15.5

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

160.9

15.5

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

160.9

15.5

ZX121

NOMESCO Finland

Central venous catheter

13.8

15.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.0

15.5

154

R04.0

ICD-10 Finland

Epistaxis

2.2

15.5

169

812

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

9.5

15.4

P16

ICPC

Acute alcohol abuse

5.8

15.4

JAF10

NOMESCO Finland

Repair of umbilical hernia

3.8

15.3

175

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

15.3

180

896

C09AA05

ATC

ramipril; oral

1.5

15.2

580

4142

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.5

15.2

119

SPAT1109

SPAT

Analgesia with portable analgesic pump

8.7

15.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

15.2

321

N18.0

ICD-10 Finland

End-stage renal disease

5.1

15.2

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.2

15.1

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

15.1

174

857

L01XE05

ATC

[U] sorafenib; oral

23.5

15.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

15.0

226

1235

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

8.1

15.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.4

14.9

211

A11CC03

ATC

alfacalcidol; systemic

3.6

14.8

191

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

16.6

14.8

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

25.2

14.7

ZXC40

NOMESCO Finland

Use of ultrasound

7.5

14.7

WVA20

NOMESCO Finland

Medicine administration

3.8

14.6

163

WX004

NOMESCO Finland

Patient-controlled sedation

11.9

14.6

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

11.9

14.6

E0000UV

ATC

1.4

14.5

817

6318

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.8

14.5

102

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.4

14.5

215

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.1

14.5

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

14.5

113

462

C579, 8461, 3

ICD-O-3

150.8

14.5

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.9

14.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

14.4

171

855

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

14.4

112

458

JFF10

NOMESCO Finland

Loop enterostomy

11.4

14.3

394

Kela drug reimbursment

Palbociclib

8.2

14.3

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.5

14.1

110

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.4

14.1

199

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

5.8

14.0

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

14.5

14.0

R06AE07

ATC

cetirizine; oral

1.4

14.0

837

6536

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

30.2

13.9

ZX112

NOMESCO Finland

Subcutaneous

3.3

13.9

207

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.5

13.8

106

430

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.6

13.8

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

17.6

13.8

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

53.6

13.8

C10AC01

ATC

colestyramine; oral

4.0

13.8

141

D76

ICPC

Malignant neoplasm pancreas

20.1

13.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

13.7

325

2057

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

9.7

13.7

L01XE33

ATC

[U] palbociclib; oral

9.7

13.7

S97

ICPC

Chronic ulcer skin

2.3

13.6

132

603

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

+∞

13.5

3A422

NOMESCO Finland

34.2

13.5

J94.9

ICD-10 Finland

Pleural condition, unspecified

8.8

13.5

L01XK01

ATC

olaparib; oral

140.7

13.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

13.4

229

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.7

13.4

155

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.0

13.3

136

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

13.9

13.2

K86.3

ICD-10 Finland

Pseudocyst of pancreas

13.9

13.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

13.2

167

857

JKA20

NOMESCO Finland

Cholecystectomy

3.5

13.2

178

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

40.3

13.1

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

15.1

13.1

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.1

13.0

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

4.7

13.0

L02BA01

ATC

tamoxifen; oral

2.4

13.0

107

452

N03AX16

ATC

pregabalin; oral

1.5

13.0

438

3031

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.7

13.0

L28

ICPC

Limited function/disability (L)

1.6

12.9

332

2148

S18

ICPC

Laceration/cut

1.4

12.8

900

7210

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

10.5

12.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.6

12.7

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

12.6

214

1221

JFB20

NOMESCO Finland

Ileocaecal resection

12.3

12.6

8460/3-C56.9

ICD-O-3

Low grade serous carcinoma of ovary

32.2

12.6

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

17.4

12.5

B03BA03

ATC

hydroxocobalamin; parenteral

2.2

12.5

134

640

SPAT1088

SPAT

Blood transfusion

7.3

12.5

L01XX46

ATC

[U] olaparib; oral

130.6

12.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

6.9

12.4

A12BA01

ATC

potassium chloride; oral

2.3

12.3

116

523

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

6.5

12.3

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

12.3

121

557

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

37.7

12.2

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

15.9

12.1

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

15.9

12.1

RD210

NOMESCO Finland

4.0

12.0

119

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

8.7

12.0

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.2

12.0

K74.3

ICD-10 Finland

Primary biliary cirrhosis

7.2

12.0

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

12.0

361

2428

V03AE02

ATC

sevelamer; oral

9.3

12.0

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

12.0

155

AN1

Coronary angiography

1.7

12.0

272

1699

K77

ICPC

Heart failure

3.4

11.9

171

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

11.9

312

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

46.9

11.9

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.5

11.9

156

C01AA05

ATC

digoxin; systemic

1.8

11.9

197

1117

JLC30

NOMESCO Finland

Pancreatoduodenectomy

11.8

M01AH05

ATC

etoricoxib; oral

0.7

11.8

840

10187

K85

ICD-10 Finland

Acute pancreatitis

4.6

11.7

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

16.5

11.7

L01XE21

ATC

[U] regorafenib; oral

30.2

11.6

D64.8

ICD-10 Finland

Other specified anaemias

3.7

11.6

133

C48.20

ICD-10 Finland

Malignant tumor in unspecified localization in the peritoneum without histology

65.2

11.6

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

65.2

11.6

UJF92

NOMESCO Finland

Capsular endoscopy

4.1

11.6

109

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

11.6

348

R77.0

ICD-10 Finland

Abnormality of albumin

23.0

11.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.1

11.5

209

A04AA03

ATC

tropisetron; systemic

11.1

11.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

11.5

177

978

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

5.7

11.5

8461/3-C48.1

ICD-O-3

High grade serous carcinoma of specified parts of peritoneum

+∞

11.5

C48.19

ICD-10 Finland

Malignant tumor in specified location in peritoneum other or unspecified histlogy

120.5

11.4

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.4

11.3

157

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

11.3

128

628

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.6

11.3

137

WX704

NOMESCO Finland

Intubation

2.0

11.2

147

765

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

11.2

361

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.4

11.2

D91

ICPC

Abdominal hernia other

5.3

11.2

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

11.2

400

R15

ICD-10 Finland

Faecal incontinence

5.7

11.2

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.4

11.1

154

A08

ICPC

Swelling

2.3

11.1

102

454

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

11.1

238

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

11.0

213

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

9.2

11.0

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.0

10.9

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

6.9

10.8

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

12.0

10.8

1CD01

NOMESCO Finland

15.5

10.8

J01CF05

ATC

flucloxacillin; systemic

2.5

10.8

346

L29.9

ICD-10 Finland

Pruritus, unspecified

3.6

10.8

137

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.7

10.8

127

L01EF01

ATC

palbociclib; oral

10.6

10.8

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.1

10.7

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

5.9

10.7

N02BE01

ATC

paracetamol; systemic, rectal

1.4

10.7

1902

17479

D07AC13

ATC

mometasone; topical

1.4

10.7

581

4416

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

60.2

10.6

474

NOMESCO Finland

60.2

10.6

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

60.2

10.6

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

60.2

10.6

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

4.1

10.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.6

981

8150

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.3

10.5

161

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.5

10.5

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

8.5

10.5

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

14.2

10.5

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

10.4

212

C48.09

ICD-10 Finland

Malignant tumor of the retroperitoneal space other or unspecified tumor

110.4

10.4

L01XX54

ATC

[U] niraparib; oral

+∞

10.4

I85

ICD-10 Finland

Oesophageal varices

+∞

10.4

1XA02

NOMESCO Finland

+∞

10.4

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

6.8

10.4

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

16.1

10.3

ZX122

NOMESCO Finland

Intra-arterial

10.6

10.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

18.8

10.3

L01CB01

ATC

etoposide; systemic

9.6

10.2

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.8

10.2

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

23.4

10.2

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.6

10.2

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

10.2

113

549

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

13.2

10.1

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.2

10.1

OAB43

SPAT

0.5

10.1

1307

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

11.3

10.0

3A064

NOMESCO Finland

8.5

10.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

10.0

146

792

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

10.0

125

638

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

40.2

10.0

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

9.9

175

1013

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.9

9.9

101

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.4

9.9

137

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.6

9.9

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

5.0

9.8

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

5.2

9.8

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.9

9.8

204

JFA80

NOMESCO Finland

Suture of colon

26.1

9.8

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.4

9.8

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

20.1

9.8

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

20.1

9.8

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.9

9.8

102

N05CF02

ATC

zolpidem; oral

1.5

9.8

325

2230

D69.5

ICD-10 Finland

Secondary thrombocytopenia

8.8

9.8

Z31.5

ICD-10 Finland

Genetic counselling

2.3

9.7

403

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

7.4

9.7

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

13.4

9.7

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

9.6

143

783

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.2

9.6

462

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

11.4

9.6

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

5.0

9.5

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

9.1

9.5

XF612

NOMESCO Finland

Measurement of central venous pressure

10.1

9.5

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

15.1

9.5

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

15.1

9.5

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

100.4

9.4

C24.00

ICD-10 Finland

Hepatic duct

+∞

9.4

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

9.4

K29.1

ICD-10 Finland

Other acute gastritis

5.1

9.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

12.4

9.3

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

8.1

9.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

9.3

140

769

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.8

9.3

102

N05AD01

ATC

haloperidol; systemic

2.5

9.3

273

WX730

NOMESCO Finland

Conventional respirator

3.3

9.2

139

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

9.2

104

510

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

9.2

526

6656

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

9.2

456

3393

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.4

9.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.7

9.2

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.7

9.2

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

9.2

250

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

9.2

213

1339

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

9.1

146

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

9.1

288

K20

ICD-10 Finland

Oesophagitis

4.0

9.1

R01AD12

ATC

fluticasone furoate; nasal

0.7

9.1

269

3791

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

9.1

482

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.9

9.0

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

9.1

9.0

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

9.0

381

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

10.1

9.0

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.0

9.0

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.3

9.0

J01MA14

ATC

moxifloxacin; systemic

1.7

9.0

173

1029

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

18.7

8.9

S01.0

ICD-10 Finland

Open wound of scalp

1.8

8.9

157

909

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

24.1

8.9

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

24.1

8.9

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

24.1

8.9

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.1

8.9

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.1

8.9

149

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

5.5

8.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

8.9

334

2354

WW200

SPAT

0.5

8.9

1304

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.9

8.8

183

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

4.8

8.8

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

8.8

128

A12AA04

ATC

calcium carbonate; oral

3.4

8.8

123

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

10.7

8.8

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.4

8.7

313

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

5.6

8.7

D06

ICPC

Abdominal pain localized other

2.0

8.7

113

586

C48.80

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum without histology

50.1

8.7

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

50.1

8.7

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

8.6

485

3693

N05BA01

ATC

diazepam; systemic, rectal

1.6

8.6

251

1670

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.0

8.6

110

569

SPAT1167

SPAT

Insertion of urinary catheter

2.3

8.6

318

A04

ICPC

Weakness/tiredness general

1.6

8.6

221

1429

C10AA07

ATC

rosuvastatin; oral

0.7

8.6

287

3958

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.5

8.6

254

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

8.5

121

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

8.5

135

755

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

27.6

8.5

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

27.6

8.5

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

8.5

101

509

GAC00

NOMESCO Finland

Biopsy of pleura

6.4

8.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

8.4

135

759

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

6.0

8.4

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.4

8.4

A07AA09

ATC

vancomycin; oral

3.9

8.4

D23

ICPC

Hepatomegaly

90.3

8.4

JAL96

NOMESCO Finland

Other excision of lesion of peritoneum

90.3

8.4

JFB40

NOMESCO Finland

Resection of transverse colon

12.8

8.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.5

8.4

107

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

6.7

8.3

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.7

8.3

209

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

8.3

100

508

N05AH04

ATC

quetiapine; oral

1.5

8.2

256

1727

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

7.1

8.2

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

8.2

386

2844

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.8

8.2

181

212

Kela drug reimbursment

Gout

2.8

8.2

181

RS221

NOMESCO Finland

3.2

8.2

130

JDE00

NOMESCO Finland

Gastrojejunostomy

14.5

8.2

E000001

ATC

1.4

8.2

388

2861

T74.1

ICD-10 Finland

Physical abuse

4.2

8.2

Z72.1

ICD-10 Finland

Alcohol use

4.2

8.2

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.9

8.2

162

N05BA02

ATC

chlordiazepoxide; systemic

2.8

8.2

182

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.1

8.2

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

33.4

8.1

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

11.7

8.1

TPX15

NOMESCO Finland

Removal of vascular injection port

6.8

8.1

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.8

8.1

N05CD07

ATC

temazepam; oral

1.5

8.1

241

1615

WX600

NOMESCO Finland

Single shot through catheter

3.6

8.0

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.0

8.0

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

8.0

133

758

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.5

8.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

7.9

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.3

7.9

112

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.4

7.8

K56.0

ICD-10 Finland

Paralytic ileus

5.7

7.8

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.4

7.8

108

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

8.5

7.8

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.2

7.8

346

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

10.8

7.8

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.9

7.8

157

N06AB04

ATC

citalopram; systemic

1.4

7.7

378

2801

205

Kela drug reimbursment

Chronic hypertension

1.3

7.7

646

5227

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.7

7.7

ZX100

NOMESCO Finland

Oral

3.7

7.7

C48.29

ICD-10 Finland

Malignant tumor in unspecified localization in peritoneum other or unspecified histology

45.1

7.7

X81

ICPC

Genital neopl female other/unspecif

45.1

7.7

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

45.1

7.7

C20

ICD-10 Finland

Malignant neoplasm of rectum

5.0

7.7

R64

ICD-10 Finland

Cachexia

15.1

7.7

K81.9

ICD-10 Finland

Cholecystitis, unspecified

4.3

7.7

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

7.7

157

2383

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.6

600

4808

D02AE01

ATC

carbamide; topical

1.8

7.6

126

715

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

7.6

110

B80

ICPC

Iron deficiency anaemia

3.1

7.6

132

C01BD01

ATC

amiodarone; systemic

2.3

7.6

310

M05BX04

ATC

denosumab; parenteral

1.9

7.6

113

620

K80.8

ICD-10 Finland

Other cholelithiasis

4.4

7.6

N02AA01

ATC

morphine; systemic, rectal

3.4

7.6

105

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

7.6

145

860

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

8.0

7.6

AP2

Catheterization of the right side of the heart

6.7

7.6

SPAT1062

SPAT

Lung clearance therapy

11.9

7.6

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

11.9

7.6

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

25.1

7.6

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.9

7.5

JJA20

NOMESCO Finland

Open biopsy of liver

10.0

7.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

7.5

134

781

R33

ICD-10 Finland

Retention of urine

1.7

7.5

148

890

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.5

233

1575

WX110

NOMESCO Finland

Local anesthesy

1.3

7.5

1341

11973

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.5

194

1256

Z71.8

ICD-10 Finland

Other specified counselling

1.4

7.4

407

3080

JN3DM

NOMESCO Finland

Abdominal very extensive MRI examination with 3 Tesla magnet

80.3

7.4

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.3

7.4

280

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

6.5

7.4

R02

ICPC

Shortness of breath/dyspnoea

1.5

7.4

216

1441

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.6

7.4

ZXA00

NOMESCO Finland

Right side

1.3

7.4

572

4574

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.0

7.4

K30

ICD-10 Finland

Functional dyspepsia

1.7

7.4

148

893

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

8.4

7.3

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

8.4

7.3

C48.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum

+∞

7.3

8000/3-C56.9

ICD-O-3

Neoplasm, malignant of ovary

+∞

7.3

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

10.9

7.3

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

6.8

7.3

SPAT1265

SPAT

Breathalyser

4.9

7.3

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

4.5

7.3

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

7.2

266

K55.8

ICD-10 Finland

Other vascular disorders of intestine

6.2

7.2

UJK12

NOMESCO Finland

Peroral cholangioscopy

15.8

7.2

Q44.6

ICD-10 Finland

Cystic disease of liver

15.8

7.2

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

7.2

258

K76.80

ICD-10 Finland

Hepatic cyst

5.4

7.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

7.2

148

OAA67

SPAT

0.4

7.2

633

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

7.2

127

L01CA04

ATC

vinorelbine; systemic

3.6

7.2

H02AB04

ATC

methylprednisolone; systemic

1.5

7.2

269

1897

JN3HE

NOMESCO Finland

Simple abdominal follow-up ultrasound

30.1

7.1

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

30.1

7.1

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.2

7.1

111

JAL31

NOMESCO Finland

Laparoscopic omentectomy

7.9

7.1

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

5.0

7.1

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

5.0

7.1

1CX08

NOMESCO Finland

6.0

7.1

K29.8

ICD-10 Finland

Duodenitis

6.0

7.1

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.0

7.1

123

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

8.8

7.0

K76.89

ICD-10 Finland

Other specified diseases of liver

10.0

7.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

7.0

256

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

7.0

469

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

7.0

330

KA1FN

NOMESCO Finland

Isotope renography

7.0

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

3.3

6.9

L02BG06

ATC

exemestane; oral

3.1

6.9

114

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

6.8

406

3109

A02BA02

ATC

ranitidine; systemic

1.4

6.8

355

2658

RS222

NOMESCO Finland

3.4

6.8

Z29.0

ICD-10 Finland

Isolation

8.3

6.8

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

8.3

6.8

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.8

151

938

JFA70

NOMESCO Finland

Suture of small intestine

11.0

6.8

Z51.88

ICD-10 Finland

Other specified medical care

2.5

6.8

198

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

9.3

6.8

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

6.8

134

806

C09DX04

ATC

valsartan and sacubitril; oral

4.5

6.8

C76.3

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Pelvis

40.1

6.8

D13

ICPC

Jaundice

40.1

6.8

JFC20

NOMESCO Finland

Other enterocolostomy

40.1

6.8

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

40.1

6.8

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

40.1

6.8

SPAT1290

SPAT

Preparation of deceased person

16.7

6.7

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

16.7

6.7

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

16.7

6.7

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.3

6.7

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

4.1

6.7

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.4

6.7

212

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.6

6.6

176

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

6.4

6.6

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

6.4

6.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

6.6

119

698

2BD01

NOMESCO Finland

7.8

6.6

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

5.5

6.6

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

5.5

6.6

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

4.6

6.6

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

12.3

6.6

OAB48

SPAT

0.4

6.6

611

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

6.6

100

553

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

10.0

6.5

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

10.0

6.5

L03.3

ICD-10 Finland

Cellulitis of trunk

4.3

6.5

U14

ICPC

Kidney symptom/complaint

3.0

6.5

119

C07AB02

ATC

metoprolol; systemic

1.3

6.5

430

3352

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.0

6.5

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

6.5

191

A10AB06

ATC

insulin glulisine; parenteral

3.7

6.5

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

5.3

6.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

6.4

174

1141

WPB10

NOMESCO Finland

Making a convalescent care decision

70.0

6.4

L04AA10

ATC

sirolimus; oral

70.0

6.4

1515

Kela drug reimbursment

70.0

6.4

3030

Kela drug reimbursment

Abemaciclib

70.0

6.4

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

70.0

6.4

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

6.4

203

RS120

NOMESCO Finland

14.3

6.4

WW200

NOMESCO Finland

Immunization

2.3

6.4

231

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

4.1

6.4

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

6.4

142

885

L15

ICPC

Knee symptom/complaint

0.7

6.4

227

3107

A99

ICPC

Disease/condition unspecnature/site

1.7

6.4

140

867

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

6.3

192

1290

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

6.6

6.3

K85.8

ICD-10 Finland

Other acute pancreatitis

6.6

6.3

Z49.2

ICD-10 Finland

Other dialysis

5.2

6.3

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

6.3

105

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

5.5

6.3

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

11.0

6.3

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

6.3

390

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

3.7

6.3

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

18.1

6.3

K08.3

ICD-10 Finland

Retained dental root

1.7

6.3

134

824

8140/3-C56.9

ICD-O-3

Adenocarcinoma, NOS, of ovary

+∞

6.2

GAE03

NOMESCO Finland

Suture of chest wall

+∞

6.2

C48.10

ICD-10 Finland

Malignant tumor in specified location in the peritoneum without histology

+∞

6.2

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.9

6.2

126

UJD10

SPAT

2.9

6.2

117

D02

ICPC

Abdominal pain epigastric

2.0

6.2

391

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

6.2

164

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.7

6.2

257

3438

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

26.7

6.2

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

26.7

6.2

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.0

6.2

WF004

NOMESCO Finland

Palliative radiotherapy

2.5

6.2

175

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.0

6.2

N06DX01

ATC

memantine; oral

0.5

6.2

783

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

3.8

6.2

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

6.1

710

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

5.7

6.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.1

256

1844

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

6.1

207

1428

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

6.1

102

D74

ICPC

Malignant neoplasm stomach

12.5

6.1

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.6

6.0

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

4.9

6.0

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

4.9

6.0

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.0

6.0

381

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

4.4

6.0

SPAT1263

SPAT

Sampling

1.3

6.0

796

6796

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

6.7

6.0

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

10.0

6.0

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

10.0

6.0

K75.4

ICD-10 Finland

Autoimmune hepatitis

10.0

6.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

6.0

218

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005719) IgG [Mass/volume] in Serum or Plasma

673

1429

5.89

312.70

2.2

2.8

13.0

10.7

g/l

17.50

631

1302

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1019

3084

4.63

309.75

3.6

2.4

2.1

2.3

g/l

19.12

962

2861

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

700

1554

5.68

309.47

4.1

1.9

35.8

41.2

u/l

0.58

635

1303

(3017143) Hepatitis C virus Ab [Presence] in Serum

746

1758

5.43

308.12

1.7

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

732

522.21

307.65

2.2

1.4

7914.7

638.3

e6/l

—

418

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

315

239

14.73

307.65

1.2

1.1

1.7

1.5

g/l

9.47

286

220

(3023487) Leukocytes [#/volume] in Peritoneal fluid

805

452.44

307.65

2.3

1.5

1273.3

355.9

e6/l

0.88

563

(3023183) Ammonium ion [Moles/volume] in Plasma

702

380

24.36

307.65

6.9

2.2

43.1

32.8

umol/l

8.78

640

313

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

616

579

13.38

307.65

2.3

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

965

2012

6.81

307.65

7.7

2.3

20.1

7.9

umol/l

16.15

899

1750

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1163

1887

9.86

307.65

4.5

1.9

0.1

0.2

g/l

96.59

1036

1753

(3007566) Smooth muscle Ab [Titer] in Serum

581

452

15.98

307.65

1.3

1.2

107.8

95.4

titre

0.19

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

487

228

25.67

307.65

3.1

2.1

445.7

818.5

u/ml

0.22

477

221

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1532

5702

4.75

307.65

4.9

2.1

56.2

58.8

u/l

0.98

1475

5160

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2183

10811

5.71

307.65

21.0

5.6

21.2

11.4

umol/l

33.00

2143

10191

(3044007) Cell count panel - Peritoneal fluid

607

287.16

307.65

2.2

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

359

334

12.19

307.65

1.6

1.4

678.1

147.9

pmol/l

10.44

340

328

(3023368) Bacteria identified in Blood by Culture

1535

5939

4.53

307.65

7.0

4.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1144

2231

8.00

307.65

4.2

4.0

64.4

28.5

ug/l

0.64

948

1820

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

594

705

10.44

307.65

3.7

3.1

746.8

3054.4

u/ml

0.72

528

599

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1005

2890

4.88

307.65

3.7

2.5

22.7

22.6

0.06

887

2446

(3024561) Albumin [Mass/volume] in Serum or Plasma

2096

9612

5.77

307.65

13.9

4.3

29.8

35.3

g/l

241.56

2049

8853

(3042936) Bacteria identified in Isolate by Culture

1337

2940

7.82

307.65

3.1

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1205

3500

5.30

307.65

6.3

3.0

0.8

mmol/l

14.01

1164

3235

(3020779) Urea [Moles/volume] in Serum or Plasma

833

1975

5.59

307.65

13.5

6.3

12.0

10.4

mmol/l

5.22

802

1871

(3033799) Differential panel - Peritoneal fluid

688

396.90

307.65

2.3

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

734

907

10.63

307.65

13.7

2.9

299.3

38.1

u/ml

14.30

724

870

(3034770) Mitochondria Ab [Titer] in Serum

570

456

15.46

307.65

1.3

1.2

653.3

1310.0

titre

—

(3028026) IgM [Mass/volume] in Serum or Plasma

629

1121

6.96

307.65

1.6

2.0

1.5

g/l

0.15

583

1015

(4281824)

768

167

63.11

307.65

1.5

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

359

391

10.39

304.35

3.4

2.9

2619.3

487.9

u/ml

0.67

328

356

(3022948) Iron [Moles/volume] in Serum or Plasma

1042

3362

4.35

288.06

3.7

2.4

11.0

12.8

umol/l

12.32

995

3117

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

762

1940

5.03

285.45

1.7

1.4

—

(3032080) INR in Blood by Coagulation assay

1870

9137

4.18

282.86

18.0

9.3

1.3

inr

0.49

520

2496

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1509

6497

3.89

272.40

9.4

2.9

51.4

34.8

u/l

2.83

1455

6141

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1018

3448

4.08

259.16

3.7

1.9

31.5

29.7

11.58

991

3346

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

213

129

17.80

257.32

1.2

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

881

2818

4.11

240.88

9.4

5.2

1.1

1.0

mmol/l

5.02

843

2613

(40768441) Liver Pathology biopsy report

200

124

17.30

238.61

2.2

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1306

5480

3.60

237.42

14.8

3.4

72.1

88.9

80.56

1275

5353

(44816559) Phosphatidylethanol [Mass/volume] in Blood

266

268

10.87

237.32

2.6

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

373

579

7.28

234.53

3.3

2.4

3.2

3.7

g/l

5.07

362

550

(3000991) Gas panel - Venous blood

662

1768

4.60

229.58

12.2

7.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

566

1344

5.03

226.89

1.9

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

798

2560

3.97

214.50

3.9

4.1

269.3

248.7

u/l

1.23

768

2430

(3044640) Blood type and Crossmatch panel - Blood

1443

6761

3.35

213.87

4.4

2.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

184

131

14.97

203.71

1.1

1.0

297.0

289.1

mg/l

0.38

162

115

(3020630) Protein [Mass/volume] in Serum or Plasma

660

1914

4.21

203.34

2.9

2.5

62.7

66.6

g/l

21.80

621

1736

(3002032) Base excess in Venous blood by calculation

664

1939

4.18

202.58

7.6

3.4

1.2

2.0

mmol/l

4.03

529

1568

(3021447) Carbon dioxide [Partial pressure] in Venous blood

664

1945

4.17

201.65

7.6

3.4

5.5

5.9

kpa

13.89

641

1891

(3012544) pH of Venous blood

674

2024

4.07

197.40

7.7

3.4

7.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

345

614

6.27

188.84

2.5

2.1

74.8

90.3

15.30

334

583

(3014111) Lactate [Moles/volume] in Serum or Plasma

616

1806

4.10

185.65

9.8

6.5

1.6

1.3

mmol/l

3.90

587

1748

(4035726)

652

2017

3.91

181.83

1.7

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

430

976

5.03

179.81

7.2

3.9

23.2

24.2

mmol/l

6.25

403

873

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

376

766

5.52

177.95

3.6

2.8

0.3

0.4

u/ml

2.09

210

450

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

290

462

6.89

176.71

1.4

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2016

12342

3.29

175.23

21.7

8.6

4.1

e9/l

0.30

1817

10638

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

310

546

6.26

171.04

2.6

2.4

223.7

206.4

2.09

298

520

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

171

146

12.41

169.66

1.2

1.1

129.5

100.4

titre

0.18

(3016650) Hepatitis A virus Ab [Presence] in Serum

220

269

8.79

168.85

1.1

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1157

5389

2.96

162.41

3.2

2.2

3.6

3.0

mg/l

7.96

1037

4533

(3022217) INR in Platelet poor plasma by Coagulation assay

782

2919

3.33

161.46

20.1

27.1

1.5

1.4

inr

1.32

362

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1120

5140

2.97

161.33

4.3

2.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

738

2718

3.33

155.08

11.3

6.3

103.3

104.5

mmol/l

6.24

726

2656

(3037522) Nuclear Ab [Titer] in Serum

712

2568

3.38

154.77

1.4

1.3

434.7

539.5

titre

0.97

167

555

(3042733) HLA Ab [Presence] in Serum

109

25.17

154.66

2.3

5.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

123

18.88

154.54

4.5

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1720

10108

2.83

151.66

7.1

3.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

162

157

10.89

147.64

1.3

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1731

10296

2.80

147.48

12.1

5.5

1.2

mmol/l

55.04

1654

9274

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

205

271

8.09

147.26

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

614

2093

3.48

145.23

2.9

1.7

1.5

10.20

513

1824

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1835

11309

2.82

144.70

13.8

6.2

1.2

mmol/l

47.56

1582

9475

(3003434) Protein [Mass/volume] in Pleural fluid

220

327

7.22

142.47

1.6

1.4

32.6

32.3

g/l

0.10

195

299

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

229

358

6.88

141.48

8.7

4.5

657.1

671.4

iu/ml

0.01

(3027945) Reticulocytes/100 erythrocytes in Blood

687

2553

3.24

140.82

3.0

2.5

2.3

1.8

13.33

632

2264

(3021879) Hepatitis B virus core Ab [Presence] in Serum

428

1173

4.13

139.16

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

204

289

7.54

137.89

1.6

1.4

1840.8

1887.3

e6/l

0.02

157

213

(3006922) Hepatitis E virus Ab [Presence] in Serum

131

103

13.30

136.49

1.1

1.0

—

(3036489) Thrombin time

332

759

4.83

136.27

2.5

2.0

22.9

21.8

1.41

316

674

(40768806) Pleura Pathology biopsy report

187

244

8.14

135.69

1.5

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

125

13.31

130.42

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

125

13.31

130.42

1.1

1.0

—

(3003396) Base excess in Arterial blood by calculation

672

2579

3.12

129.27

10.2

6.7

0.0

1.1

mmol/l

6.75

563

2022

(3027801) Oxygen [Partial pressure] in Arterial blood

673

2593

3.10

128.51

10.2

6.7

13.0

12.2

kpa

3.91

646

2469

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

673

2594

3.10

128.41

10.2

6.7

4.9

5.1

kpa

7.29

646

2472

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

381

1021

4.16

127.24

2.0

1.7

1.2

1.5

g/l

5.54

314

874

(42870588) Differential panel, method unspecified - Blood

1326

7271

2.57

127.17

8.2

5.6

—

(3024471) HLA-A [Type]

18.97

124.98

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

207

331

6.68

124.93

1.5

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

24.16

124.50

2.7

2.1

—

(3026782) Osmolality of Urine

899

4115

2.75

124.26

3.6

2.5

501.1

554.4

mosm/kgh2o

12.94

802

3473

(3024932) HLA-DR beta [Type]

19.13

124.19

1.0

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1213

6456

2.56

122.82

4.5

3.0

54.3

83.4

e6/l

1.03

972

4866

(3007164) IgA [Mass/volume] in Serum or Plasma

798

3462

2.83

122.02

1.8

1.5

4.4

2.5

g/l

38.64

642

2036

(40768797) Stomach Pathology biopsy report

638

2458

3.07

121.14

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

17.78

120.00

32.4

28.0

7.4

7.3

ug/l

0.17

(3022096) Basophils/100 leukocytes in Blood

1587

9643

2.50

119.60

8.7

5.8

0.6

0.7

3.23

1527

8952

(3028308) Erythrocytes [#/volume] in Pleural fluid

181

263

7.29

119.39

1.5

1.4

30696.8

82293.4

e6/l

1.02

112

159

(3019069) Monocytes/100 leukocytes in Blood

1623

9974

2.50

119.16

9.3

6.1

9.4

8.8

8.12

1566

9286

(3006504) Eosinophils/100 leukocytes in Blood

1613

9914

2.49

117.93

8.9

5.8

2.6

2.9

4.00

1554

9197

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

191

303

6.69

116.05

1.5

1.4

129.1

125.2

u/ml

0.11

(3018418) pH of Serum or Plasma

1233

6773

2.47

114.61

7.4

3.9

7.4

0.07

242

1266

(3002030) Lymphocytes/100 leukocytes in Blood

1636

10208

2.46

114.35

9.0

5.9

21.7

27.3

66.30

1570

9437

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

788

3514

2.73

113.10

2.2

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

185

292

6.72

112.91

1.3

1.1

341.0

301.9

u/ml

0.72

140

171

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

255

550

5.00

111.65

5.9

3.0

2.0

1.6

mg/l

8.80

244

498

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

190

312

6.46

111.58

1.3

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

471

1595

3.35

110.42

6.3

2.7

4.7

4.5

kpa

0.81

442

1546

(3006315) Basophils [#/volume] in Blood

1667

10650

2.41

108.08

8.5

5.5

0.0

e9/l

9.34

1440

9032

(3001604) Monocytes [#/volume] in Blood

1662

10605

2.41

108.04

8.5

5.5

0.6

e9/l

1.23

1436

8989

(3030467) Casts [#/volume] in Urine by Automated count

1103

5934

2.42

105.24

4.3

2.9

1.0

0.5

e6/l

3.58

872

4419

(3019198) Lymphocytes [#/volume] in Blood

1681

10878

2.37

104.33

8.6

5.6

1.4

1.9

e9/l

18.82

1465

9405

(3018010) Neutrophils/100 leukocytes in Blood

1592

10068

2.36

104.19

8.8

5.7

61.7

57.7

26.84

1535

9357

(3013115) Eosinophils [#/volume] in Blood

1692

10991

2.37

103.93

8.9

5.8

0.2

e9/l

10.46

1461

9477

(3002173) Hemoglobin [Mass/volume] in Arterial blood

554

2139

2.98

103.36

11.3

7.4

108.6

121.2

g/l

39.37

539

2053

(3013826) Glucose [Moles/volume] in Serum or Plasma

1899

13002

2.45

102.95

11.1

4.2

7.1

6.8

mmol/l

6.70

1848

12134

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

178

297

6.33

102.80

1.2

—

(3012441) Differential panel - Pleural fluid

161

242

7.00

102.79

1.7

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

372

1135

3.63

102.27

1.8

1.4

—

(3045788) Cell count panel - Pleural fluid

159

238

7.02

101.90

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

208

414

5.35

99.68

1.5

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

147

207

7.44

99.56

1.3

337.3

322.1

u/l

0.08

138

197

(3018095) Leukocytes [#/volume] in Urine

1293

7595

2.31

99.17

5.7

3.4

87.9

119.7

e6/l

0.95

1000

5253

(3010375) cycloSPORINE [Mass/volume] in Blood

12.74

96.97

40.9

23.4

117.2

111.3

ug/l

0.32

(3048929) Epstein Barr virus Ab [Presence] in Serum

206

421

5.20

95.76

1.3

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

589

2441

2.79

95.72

2.1

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

509

1951

2.97

95.65

3.0

2.5

82.0

69.3

e9/l

6.17

371

1467

(3016502) Oxygen saturation in Arterial blood

569

2322

2.82

95.19

11.1

7.0

96.0

95.5

0.87

550

2235

(36304419) Bacteria [Presence] in Urine

1055

5761

2.34

95.17

4.3

2.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

589

2452

2.78

94.82

2.1

1.6

—

(40758558) Short blood count panel - Blood

1004

5386

2.35

94.19

17.2

6.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

237

555

4.57

93.57

1.5

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2265

17180

2.70

92.65

23.9

6.7

125.3

78.0

u/l

68.95

2218

16035

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

715

3334

2.54

91.13

3.7

2.8

3.0

2.3

e6/l

0.87

398

1747

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

118

144

8.51

90.18

2.3

—

(3026008) Bacteria identified in Urine by Culture

1144

6596

2.25

89.28

3.5

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

303

882

3.73

88.90

2.5

1.9

1.2

2.5

ug/l

1.44

287

764

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1369

8505

2.20

88.44

4.5

2.6

234.1

140.5

ug/l

15.08

1307

7768

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

116

142

8.48

88.42

1.2

—

(3003181) Sodium [Moles/volume] in Urine

183

363

5.33

87.89

1.4

1.3

46.4

62.5

mmol/l

5.78

105

289

(3000850) Epithelial cells [#/volume] in Urine

856

4416

2.35

86.60

3.5

2.4

7.2

5.1

e6/l

3.33

780

3853

(3036782) Glucose [Moles/volume] in Pleural fluid

143

227

6.59

86.58

1.4

6.2

6.3

mmol/l

0.18

132

208

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

159

283

5.90

85.83

4.0

2.4

1216.1

1217.7

u/ml

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1947

14163

2.24

81.25

6.0

4.0

440.1

2254.5

e6/l

2.03

222

(3000570) Elastase.pancreatic [Mass/mass] in Stool

202

471

4.55

79.97

1.5

1.3

233.2

275.2

ug/g

1.86

132

278

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1903

23109

0.44

79.74

5.0

5.1

2.5

2.7

mmol/l

31.26

1678

21089

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1839

22577

0.45

77.87

4.7

4.5

4.2

4.6

mmol/l

40.15

1639

20699

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1823

22397

0.46

75.41

4.6

4.5

1.3

1.5

mmol/l

37.14

1614

20415

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

143

271

5.51

72.10

7.2

6.0

12.1

11.8

mg/l

0.26

129

253

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

8.76

71.56

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

111

166

6.92

71.03

1.3

10.3

12.3

u/l

0.44

102

155

(3035880) pH of Pleural fluid

101

136

7.67

71.00

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

199

507

4.15

70.08

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

703

3607

2.27

69.82

3.5

2.6

1.3

1.1

e6/l

0.63

388

2013

(46235355) HIV 1 and 2 tests - Meaningful Use set

514

2303

2.51

69.41

1.9

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

329

1202

2.97

66.08

13.4

9.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

242

742

3.48

65.11

2.1

2.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

320

1164

2.98

64.73

13.4

8.5

23.4

24.2

mmol/l

3.02

302

1078

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1818

13464

2.01

64.22

9.4

2.8

138.3

49.0

u/l

65.92

1752

12307

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

762

4175

2.14

63.35

4.4

3.4

329.8

712.5

ng/l

0.93

650

3490

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

150

6.74

61.33

1.1

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

769

4291

2.09

60.51

2.4

1.6

2.9

1.4

mg/l

10.78

674

3319

(3015377) Calcium [Moles/volume] in Serum or Plasma

1184

7710

1.93

59.83

7.6

3.3

2.3

2.4

mmol/l

22.49

1101

6665

(3004119) Hemoglobin [Mass/volume] in Venous blood

333

1299

2.78

58.97

7.4

2.8

113.2

128.6

g/l

28.64

327

1262

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

187

523

3.76

57.65

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

499

2394

2.32

56.92

5.0

3.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

505

2439

2.31

56.70

2.2

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

319

1267

2.71

54.38

5.9

3.4

1.1

1.9

mmol/l

1.92

214

948

(3009343) pH of Capillary blood

327

1319

2.68

54.06

5.9

3.4

7.4

0.47

171

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

329

1335

2.66

53.73

5.9

3.4

4.8

5.2

kpa

8.15

309

1241

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1793

21581

0.53

53.32

4.3

4.0

1.3

mmol/l

0.33

1588

19482

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

324

1318

2.65

52.61

1.9

1.6

—

(3019060) Gas panel - Arterial blood

355

1511

2.55

52.53

6.3

4.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1057

6886

1.86

51.22

4.7

2.9

3334.5

1526.6

ng/l

8.94

974

5966

(3052851) Hemolysis interference index of Serum or Plasma

196

611

3.37

51.16

6.2

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

272

1029

2.82

50.80

7.3

2.8

24.4

25.3

mmol/l

3.19

264

997

(1616796) Gas panel - Central venous blood

161

448

3.75

49.93

4.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

153

412

3.87

49.73

5.8

3.8

156.6

25.6

u/ml

4.47

145

399

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

12.84

49.52

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

7.48

49.24

1.6

1.5

66.7

63.5

0.29

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

12.15

48.87

1.1

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

379

1722

2.39

48.47

2.5

2.3

425.0

379.1

nmol/l

2.05

366

1572

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

201

5.12

47.14

1.3

1.2

54.9

60.4

u/l

0.39

146

(3051651) Icteric interference index of Serum or Plasma

122

6.38

45.41

5.4

3.2

—

(3024928) Oxygen saturation in Venous blood

151

429

3.66

45.40

5.6

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1881

14891

1.81

45.05

6.9

3.9

—

(3037121) Protein [Mass/volume] in Urine

208

731

2.99

44.31

5.8

2.9

0.3

g/l

0.29

138

283

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1921

22368

0.55

44.08

4.9

4.7

6.3

6.0

mmol/l

13.90

1731

20178

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

126

323

4.04

43.83

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

148

437

3.52

41.97

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

148

437

3.52

41.97

1.5

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

320

1437

2.39

41.73

9.9

6.8

23.8

24.8

mmol/l

3.58

304

1340

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

8.94

41.09

1.2

394.8

123.4

ug/l

0.46

(3021589) Normoblasts [#/volume] in Blood

1341

9840

1.70

40.08

20.1

9.2

0.0

e9/l

1.61

1077

8000

(3024980) IgG subclass 4 [Mass/volume] in Serum

104

253

4.23

38.81

1.7

1.4

0.9

0.8

g/l

0.24

197

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

656

3954

1.86

38.71

1.3

1.2

4.0

1.9

u/ml

0.96

153

1052

(3015235) Bicarbonate [Moles/volume] in Capillary blood

160

523

3.18

38.55

3.7

3.3

23.0

25.2

mmol/l

6.30

143

454

(3010421) pH of Blood

164

550

3.11

37.84

5.4

4.4

7.4

0.11

143

459

(3001893) Eosinophils/100 leukocytes in Pleural fluid

6.83

37.80

1.6

1.5

3.1

3.4

0.07

(3001186) Copper [Moles/volume] in Serum or Plasma

12.03

37.69

1.5

1.0

15.3

17.2

umol/l

0.96

(3012501) Base excess in Blood by calculation

147

463

3.30

37.64

5.6

4.7

2.7

mmol/l

0.01

316

(3003694) ABO and Rh group [Type] in Blood

878

5813

1.75

37.63

1.6

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

689

4257

1.82

37.35

6.1

3.0

2.5

mmol/l

12.42

617

3729

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1823

21307

0.58

37.32

7.6

5.9

42.0

40.2

mmol/mol

6.26

1689

19558

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

19.53

37.11

1.1

1.3

1.0

0.8

ml/s/173m2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

150

5.18

36.58

3.5

1.4

1.0

g/l

0.03

150

(3019309) Folate [Moles/volume] in Red Blood Cells

696

4343

1.80

36.38

2.0

1.7

1273.2

1175.4

nmol/l

1.53

568

3228

(3028626) Oxygen [Partial pressure] in Capillary blood

147

481

3.17

35.34

4.6

3.2

8.2

8.0

kpa

0.55

138

447

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

396

2075

2.06

34.96

4.5

2.7

414.1

201.0

ng/l

6.80

373

1890

(3051611) Lipemic interference index of Serum or Plasma

231

4.18

34.62

5.5

3.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

7.20

34.35

1.3

3.8

3.5

mmol/l

0.28

(3017181) Myelocytes/100 leukocytes in Blood

359

1828

2.11

34.18

4.6

4.0

1.0

0.9

0.25

164

503

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

221

4.17

33.18

2.7

3.0

7.4

31.1

nmol/l

0.46

215

(3022313) Gas panel - Capillary blood

226

966

2.46

32.65

6.5

3.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

8.35

32.12

1.5

1.3

24.0

20.6

0.26

(3022493) Free Hemoglobin [Mass/volume] in Plasma

6.52

31.99

5.2

3.8

68.2

72.1

mg/l

0.10

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1131

8277

1.62

31.70

5.0

3.3

64.4

120.6

ng/l

0.49

934

6023

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

127

5.22

31.65

2.1

2.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

120

5.35

31.56

1.3

1.2

160.9

79.7

u/l

3.27

101

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

5.35

31.56

1.3

1.2

46.3

20.3

u/l

1.60

100

(40760892) CBC W Ordered Manual Differential panel - Blood

686

4456

1.72

30.36

6.6

4.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

324

1660

2.08

30.18

6.4

3.6

125.4

91.4

ng/l

5.14

295

1418

(3025941) Bacteria identified in Stool by Culture

219

959

2.39

29.95

1.4

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

182

734

2.58

29.69

2.5

2.2

1096.7

869.2

ug/l

0.17

172

694

(1761868) Lipid panel - Serum or Plasma

478

7531

0.56

28.82

2.9

3.0

—

(40767503) Oxygen content in Capillary blood by calculation

134

469

2.95

28.67

3.2

2.6

13.9

16.0

5.81

242

(3002179) Metamyelocytes/100 leukocytes in Blood

317

1649

2.04

28.26

4.5

3.8

0.7

0.6

0.53

106

355

(3021960) Folate [Moles/volume] in Serum or Plasma

784

5361

1.64

28.19

1.9

1.5

17.9

20.6

nmol/l

6.69

721

4510

(3008838) Polymorphonuclear cells/100 leukocytes in Peritoneal fluid

+∞

28.17

1.9

0.0

22.3

—

(3020891) Body temperature

208

918

2.37

27.92

7.7

4.4

—

(3021901) Oxygen saturation in Capillary blood

119

396

3.09

27.81

3.0

3.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

5.55

27.73

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

107

338

3.25

27.28

3.4

3.6

2.0

1.4

0.70

259

(3000494) Fungus identified in Specimen by Culture

418

2440

1.84

26.34

1.7

1.4

—

(3047181) Lactate [Moles/volume] in Blood

165

674

2.54

26.20

7.9

6.2

1.5

1.3

mmol/l

1.17

141

591

(44786800) Granulocytes/100 leukocytes in Body fluid

11.35

25.80

1.3

1.4

21.4

23.0

0.06

(3026493) Urate [Moles/volume] in Serum or Plasma

829

5854

1.59

25.68

4.1

2.7

4869.8

5546.4

umol/l

0.17

740

5057

(3043409) Potassium [Moles/volume] in Arterial blood

166

687

2.51

25.64

6.0

4.1

3.9

mmol/l

0.20

155

646

(3004588) Protein electrophoresis panel - Serum or Plasma

306

1629

1.99

25.47

1.6

2.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

7.99

25.15

1.3

1.2

1.8

mmol/l

0.06

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

122

4.75

25.02

1.6

1.7

5.5

5.4

u/l

0.01

(3024891) Influenza virus A+B Ag [Presence] in Specimen

124

458

2.79

24.05

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

8.46

24.01

1.6

1.5

13.5

7.4

0.58

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.47

23.91

1.4

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

108

374

2.96

23.57

1.7

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

197

3.73

22.91

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

5.37

22.31

2.8

1.7

31.2

7.4

umol/l

2.65

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

108

388

2.86

22.07

5.4

3.5

62.8

57.7

2.97

108

388

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

195

927

2.19

21.89

7.8

5.0

1.8

1.6

0.69

181

862

(3016038) Potassium [Moles/volume] in Urine

141

4.18

21.73

1.4

1.1

35.2

35.6

mmol/l

0.03

124

(40768804) Tissue Pathology biopsy report

1136

8829

1.48

21.69

2.5

2.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

8.79

21.54

4.5

3.9

78.2

36.8

u/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

1313

10514

1.47

21.46

7.6

4.6

0.0

estimate

0.80

308

1913

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

180

835

2.24

21.46

7.5

3.5

23.8

24.8

mmol/l

2.42

171

769

(3021440) Promyelocytes/100 leukocytes in Blood

308

1742

1.86

21.24

4.9

4.0

0.2

0.13

143

462

(3007930) Methemoglobin/Hemoglobin.total in Blood

191

914

2.17

21.09

7.8

5.0

0.9

0.79

179

853

(3009261) Glucose [Presence] in Urine by Test strip

1325

10656

1.46

21.02

5.6

3.4

0.0

estimate

1.08

309

1848

(3028271) Lactate [Moles/volume] in Capillary blood

351

2.89

20.74

2.5

1.8

1.7

mmol/l

0.43

340

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

121

480

2.59

20.42

1.8

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

164

749

2.26

20.30

1.6

3.4

1.4

2.3

ratio

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

327

1910

1.81

20.29

2.7

2.3

7.4

8.2

ug/l

0.32

297

1683

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

167

770

2.24

20.20

1.6

3.4

55.6

52.5

mg/l

0.12

132

619

(3042631) Mycobacterium sp identified in Specimen

310

2.97

19.86

1.7

3.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

166

770

2.23

19.79

1.7

3.4

71.3

55.0

mg/l

1.03

131

616

(3011648) Oxygen content in Venous blood

156

3.84

19.75

2.4

2.7

8.7

11.3

3.74

156

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1641

0.27

19.56

1.6

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

418

6276

0.61

19.20

1.9

1.6

1.3

mmol/l

1.57

382

5209

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

4.41

18.96

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

4.41

18.96

1.4

1.7

—

(3022145) Colonoscopy Study observation

356

2174

1.73

18.89

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

196

3.42

18.63

2.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

201

3.39

18.62

2.0

1.3

—

(3015736) pH of Urine

1037

8095

1.45

18.50

5.0

3.2

5.5

5.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

197

3.41

18.49

2.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

198

3.39

18.34

2.0

1.3

—

(3008295) Osmolality of Serum or Plasma

194

3.41

18.21

1.2

1.3

274.9

276.4

mosm/kgh2o

0.22

149

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

446

6522

0.62

18.11

3.5

4.4

21.8

21.7

0.02

174

3328

(3035350) Ketones [Presence] in Urine by Test strip

1286

10479

1.42

17.95

5.6

3.4

0.0

estimate

0.00

307

1896

(3037756) Immunofixation for Serum or Plasma

121

513

2.42

17.77

1.3

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

198

3.34

17.65

2.0

1.3

—

(3025159) Blasts/100 leukocytes in Blood

285

1665

1.79

17.59

5.0

4.0

0.0

0.3

0.77

119

395

(40760888) Immunoglobulin light chains.free panel - Serum

127

554

2.35

17.51

1.6

3.5

—

(3026361) Erythrocytes [#/volume] in Blood

2357

25048

0.62

17.29

65.0

19.5

3.9

4.5

e12/l

286.53

2264

24182

(3000963) Hemoglobin [Mass/volume] in Blood

2358

25056

0.62

17.28

65.6

19.6

117.5

135.1

g/l

307.65

2315

24612

(3024522) Salmonella sp identified in Specimen by Organism specific culture

201

3.29

17.24

2.0

1.3

—

(3035941) MCH [Entitic mass]

2357

25045

0.62

17.21

64.7

19.4

30.5

30.4

1.07

2312

24597

(3010813) Leukocytes [#/volume] in Blood

2358

25053

0.62

17.20

65.0

19.5

6.9

6.7

e9/l

2.22

2271

24190

(3024731) MCV [Entitic volume]

2358

25044

0.62

16.96

64.8

19.4

92.5

91.4

16.08

2313

24596

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1834

20456

0.70

16.95

4.7

4.6

2.4

2.2

mu/l

0.96

1664

18487

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

171

853

2.07

16.94

2.4

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

690

5051

1.49

16.85

4.9

3.4

—

(3007461) Platelets [#/volume] in Blood

2358

25039

0.62

16.83

65.0

19.5

225.5

247.9

e9/l

24.78

2273

24262

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

299

1795

1.75

16.78

5.4

2.5

50.3

63.6

ml/min/173m2

7.05

136

727

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

112

471

2.44

16.76

2.0

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

119

4.00

16.73

2.3

3.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

8.46

16.26

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

124

3.84

15.83

1.7

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

152

3.54

15.82

1.3

1.2

7.6

7.1

g/l

0.25

110

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

524

2.31

15.64

1.3

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

304

4728

0.60

15.63

2.4

3.1

0.9

0.8

ug/l

0.48

203

3216

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

121

3.85

15.56

1.8

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1060

0.20

15.50

1.4

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

118

526

2.30

15.50

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

118

529

2.29

15.30

1.3

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

152

3.47

15.09

1.3

1.2

0.6

0.4

g/l

1.32

110

(3028192) IgG subclass 2 [Mass/volume] in Serum

152

3.47

15.09

1.3

1.2

2.8

3.0

g/l

0.33

108

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

155

786

2.03

14.70

2.2

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

365

2.51

14.59

1.1

1.3

257.2

195.6

miu/ml

0.34

157

(4062490)

151

3.42

14.52

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

305

1913

1.67

14.51

7.1

3.8

1.2

mmol/l

8.78

290

1653

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

8.31

14.51

1.0

1.1

14.4

24.0

u/l

1.00

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

178

3.19

14.25

2.8

1.8

6268.3

1362.9

u/l

0.35

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

916

1.94

14.19

1.6

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

916

1.94

14.19

1.6

2.4

4.1

3.8

g/l

0.93

127

668

(3039000) Anion gap in Blood

113

514

2.25

14.17

9.3

6.8

12.0

11.2

mmol/l

1.20

101

456

(3018572) Chloride [Moles/volume] in Blood

113

514

2.25

14.17

9.3

6.8

104.4

105.2

mmol/l

0.70

101

456

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

917

1.93

14.15

1.6

2.4

6.8

7.4

g/l

3.77

127

696

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.05

13.98

9.2

8.5

5.5

5.7

mmol/l

0.13

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

858

1.94

13.59

1.6

2.4

3.1

g/l

0.27

128

685

(21494755) Public health laboratory ask at order entry panel

1499

0.37

13.52

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

350

2.47

13.37

1.9

1.6

—

(40768446) Kidney Pathology biopsy report

4.48

13.30

1.8

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

155

815

1.95

13.28

1.5

1.8

42.8

38.4

u/l

1.15

133

709

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

8.55

13.25

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

420

2.33

13.21

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

5.13

13.15

1.6

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

652

4921

1.42

13.07

1.8

1.7

528.9

21738485.4

pmol/l

2.86

546

4039

(3020191) Ethanol [Moles/volume] in Serum or Plasma

127

3.50

13.05

2.0

1.2

1.0

1.1

promille

0.22

103

(3014891) Appearance of Pleural fluid

6.40

12.82

2.6

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

868

1.91

12.82

1.6

2.4

12.5

10.4

g/l

3.83

136

737

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1143

9494

1.35

12.62

2.4

2.0

88.1

94.8

pmol/l

6.21

647

4717

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

8.46

12.37

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

3.87

12.35

1.3

1.1

193.5

82.1

u/l

1.85

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.11

12.30

1.9

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.11

12.30

1.9

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

630

8103

0.71

12.20

3.9

5.0

5.5

3.6

ug/l

0.53

550

7259

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

3.83

12.17

1.3

1.1

89.6

26.9

u/l

1.56

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.94

12.15

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

230

2.73

12.06

3.6

4.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

157

3.09

11.70

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

2.92

11.66

4.3

2.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.61

11.65

4.8

1.6

8700.4

4487.5

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

361

2.34

11.61

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

226

2.69

11.35

1.7

1.6

—

(3002256) Pathology report gross observation

398

2808

1.49

11.24

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

126

655

1.97

11.20

1.6

2.4

0.0

g/l

0.00

112

604

(3035637) Corticotropin [Mass/volume] in Plasma

234

2.64

11.15

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

282

2.48

11.08

1.9

1.5

—

(40761536) Microorganisms panel - Urine sediment

278

1822

1.58

11.01

7.3

3.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

102

494

2.11

11.01

2.8

2.2

113.6

127.6

g/l

6.84

358

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

133

711

1.91

10.90

1.6

2.3

0.0

g/l

0.07

119

644

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

182

2.84

10.70

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

126

667

1.93

10.63

1.6

2.3

0.0

g/l

0.50

112

605

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.50

10.48

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

109

553

2.01

10.40

2.2

1.5

0.2

g/l

1.25

100

530

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

185

2.79

10.39

1.3

1.2

1.4

1.5

nmol/l

0.31

166

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

840

6816

1.33

10.35

2.3

2.0

192.3

240.1

u/l

0.90

796

6337

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.54

10.32

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1499

16776

0.77

10.26

3.9

3.8

15.0

14.9

pmol/l

0.29

1352

15084

(3043410) Blood group antigens tested for on Red Blood Cells

4.34

10.04

1.7

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

114

3.28

9.99

1.2

1.4

1.3

1.2

nmol/l

0.29

(40761535) Cells panel - Urine sediment

269

1792

1.55

9.91

4.7

3.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

111

579

1.96

9.80

2.1

1.5

1.1

1.2

g/l

2.00

102

554

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

8.16

9.74

1.1

1.0

—

(3025315) Body weight

7.40

9.70

5.6

4.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

499

2.02

9.64

1.7

1.9

13.4

11.9

mg/l

0.75

463

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

316

2.28

9.48

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

142

813

1.79

9.40

1.6

2.5

0.7

1.2

g/l

0.96

124

691

(3033705) Calcium.ionized [Moles/volume] in Venous blood

266

2.36

9.02

4.0

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

273

2.34

8.97

1.6

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.17

8.88

1.4

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

131

749

1.79

8.73

1.6

2.3

33.9

37.5

g/l

7.08

116

636

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

119

661

1.84

8.72

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

181

1132

1.64

8.70

2.4

—

(3011412) CD3 cells [#/volume] in Blood

175

2.66

8.62

2.1

2.2

0.9

1.0

e9/l

0.26

105

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

16.32

8.55

1.2

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

399

2.06

8.44

1.2

—

352.7

—

(44790047)

225

2.43

8.40

1.9

1.4

—

(44806118)

225

2.43

8.40

1.9

1.4

—

(44790049)

225

2.43

8.40

1.9

1.4

—

(44790048)

225

2.43

8.40

1.9

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.11

8.18

4.4

4.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

432

2.00

8.14

1.2

1.4

1.1

0.8

nmol/l

2.55

355

(3009508) Creatinine [Moles/volume] in Urine

886

7446

1.28

7.97

3.9

3.1

6.8

7.4

mmol/l

3.85

755

6225

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

131

2.85

7.95

1.9

2.3

10.3

13.1

0.63

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.66

7.73

4.0

2.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.19

7.73

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

136

815

1.70

7.72

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

124

2.85

7.53

1.7

2.4

—

(3029937) Albumin [Presence] in Urine by Test strip

695

5712

1.29

7.36

6.1

3.8

0.0

estimate

0.88

289

1828

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.69

7.18

1.2

1.4

107.0

76.9

umol/l

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

162

2.55

7.18

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

174

2.49

7.17

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

174

2.49

7.17

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

174

2.49

7.17

1.8

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

111

2.90

7.16

2.2

1.6

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

6.90

7.15

1.2

1.3

—

mmol/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

2.14

7.15

1.6

1.4

—

(3036603) Volume of Urine

135

2.69

6.99

1.5

1.6

1866.0

1944.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.06

6.89

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.06

6.89

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.06

6.89

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.06

6.89

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

2.69

6.83

2.0

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

497

1.84

6.79

2.9

3.0

0.8

nmol/l

0.04

380

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

168

2.46

6.68

1.7

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

244

2.19

6.64

1.3

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

268

1935

1.43

6.63

1.9

2.2

151.7

157.7

ug/g

0.09

225

1518

(3019225) pH of Specimen

300

2210

1.40

6.63

7.6

4.1

—

(3006653) Thiamine [Moles/volume] in Blood

106

2.85

6.52

1.3

1.1

118.4

133.9

nmol/l

1.13

106

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2317

24142

0.76

6.43

29.9

9.7

28.5

25.6

u/l

9.40

2273

23128

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2334

22212

1.31

6.42

43.5

12.8

32.6

25.2

mg/l

24.21

2232

17248

(36660697) Celiac disease serology panel - Serum

207

1432

1.48

6.42

1.1

1.2

—

(1002224) Polysomnography panel

761

0.40

6.40

1.0

1.1

—

(3012516) Albumin [Mass/volume] in Urine

849

7250

1.25

6.37

3.8

3.2

431.6

249.9

mg/l

0.68

608

4525

(3016750) Collection duration of Urine

136

2.59

6.37

1.9

511.4

484.7

min

0.49

101

(3029075) Extractable nuclear Ab panel - Serum

3.46

6.28

1.0

—

(3044927) Protein electrophoresis panel - Urine

237

2.17

6.26

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

278

2.07

6.19

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

888

7647

1.24

6.12

4.6

3.9

24.2

8.3

mg/mmol

5.00

621

4801

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

2.56

6.03

1.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

209

2.22

5.98

4.4

3.6

62.3

59.0

0.35

137

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

112

2.70

5.92

2.0

2.3

460.1

558.1

e6/l

0.35

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

108

2.70

5.75

2.0

2.4

0.2

e9/l

1.25

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

114

2.65

5.73

1.7

1.5

—

(3004775) Volume in Urine collected for unspecified duration

194

2.24

5.70

1.8

2.2

912.3

596.9

1.91

126

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

138

2.48

5.69

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.98

5.68

1.5

1.3

—

(4306422)

281

2.01

5.66

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.71

5.64

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

4.07

5.62

1.5

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

289

1.99

5.61

1.4

1.2

4.6

4.4

u/ml

0.06

119

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

289

1.99

5.61

1.4

1.2

4.4

5.1

u/ml

0.13

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.94

5.57

1.5

1.3

—

(4198724)

3.96

5.44

2.1

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1032

9114

1.21

5.39

3.1

2.1

71.0

78.7

nmol/l

13.60

946

8054

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.41

5.30

1.6

1.1

—

(3045142) Bone marrow Pathology biopsy report

268

2.00

5.27

1.4

1.3

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

+∞

5.21

1.0

0.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

115

2.54

5.12

1.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

647

5481

1.24

5.05

5.7

3.1

—

(3020393) Adenovirus Ag [Presence] in Stool

5.28

5.04

2.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

180

2.18

4.94

2.0

2.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

200

2.12

4.92

2.4

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

680

0.45

4.91

1.5

1.7

5.2

4.2

mg/l

0.34

496

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

158

2232

0.69

4.88

1.4

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

589

1.63

4.86

5.6

4.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.71

4.84

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.01

4.77

1.3

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

458

0.35

4.73

1.3

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.96

4.71

1.5

2.4

237.9

168.3

2.11

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.95

4.71

1.2

1.1

—

(4094501)

653

0.45

4.67

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

785

0.50

4.64

1.7

1.8

—

(40761511) CBC panel - Blood by Automated count

2249

23362

0.81

4.62

39.9

12.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

111

2.45

4.46

2.4

3.1

231.8

202.8

u/l

0.97

111

(3006245) CD3-CD19+ cells/100 cells in Blood

3.01

4.39

2.2

2.5

7.5

10.4

0.65

(3014271) Vancomycin [Susceptibility]

112

2.42

4.38

3.6

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

598

1.59

4.37

1.9

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.10

4.36

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.24

4.35

1.0

1.2

71.8

77.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.74

4.35

2.1

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2037

21323

0.83

4.24

44.2

12.7

74.0

77.0

ml/min/173m2

5.81

1817

17328

(3017704) Immunofixation for Urine

127

2.30

4.19

1.4

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

127

2.30

4.19

1.9

2.2

248.5

165.0

ug/min

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

380

1.73

4.19

5.3

3.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

173

2.10

4.17

1.3

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.94

4.16

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

570

1.58

4.05

1.6

0.5

0.2

iu/ml

0.44

114

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

333

1.76

3.99

1.1

199.2

66.3

iu/ml

0.37

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.68

3.99

2.1

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.68

3.99

2.2

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

190

2.01

3.98

2.3

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

220

2846

0.75

3.94

4.4

4.7

30.9

32.8

1.51

151

1808

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

144

2.17

3.92

1.6

1.4

15.7

13.4

umol/l

0.78

134

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

112

2.33

3.92

3.0

2.6

46.2

38.8

1.29

(3044242) Glucose [Moles/volume] in Arterial blood

112

2.33

3.92

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

900

8044

1.18

3.80

6.0

3.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

511

1.58

3.71

1.4

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.01

3.70

1.0

1.2

68.0

70.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

129

2.18

3.63

1.3

12.5

11.5

mmol/l

0.26

(3013512) EKG study

761

6745

1.18

3.51

5.3

3.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

260

3239

0.78

3.49

1.2

17.2

15.6

u/ml

0.10

1198

(3004451) EKG impression Narrative

106

2.28

3.45

1.2

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.77

3.42

3.8

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.77

3.42

3.8

2.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1367

0.68

3.31

2.3

31.9

19.8

au/ml

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.48

3.29

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1210

0.67

3.26

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.34

3.24

2.9

2.3

1270.3

1329.6

u/ml

0.06

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

578

1.50

3.22

2.4

2.3

118.4

100.3

ug/min

0.16

343

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

105

735

1.45

3.21

1.1

1.2

1.0

u/ml

—

(3028433) Virus identified in Specimen by Culture

2.63

3.13

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

566

1.50

3.12

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.51

3.11

2.0

2.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

180

1.90

3.09

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

344

1.64

3.09

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

166

1.94

3.09

2.2

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

3.09

2.5

60.0

244.2

e6/l

—

(40768800) Prostate Pathology biopsy report

560

0.53

3.09

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.47

2.95

2.2

2.0

—

(4010399)

114

1555

0.72

2.95

1.3

1.4

—

(4268621)

198

1.83

2.93

2.7

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

128

2.04

2.91

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

149

1.96

2.89

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

149

1.96

2.89

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

149

1.96

2.89

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.94

2.84

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.94

2.84

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.94

2.84

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

113

1531

0.73

2.82

2.1

2.2

11.5

12.5

nmol/l

0.51

1344

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

123

2.04

2.81

2.5

2.2

463.9

581.7

e6/l

0.41

(3049717) Cytology report of Urine Cyto stain

112

816

1.39

2.78

2.2

2.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.92

2.77

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.43

2.71

1.3

14.4

8.4

ug/l

1.86

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.98

2.69

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

156

1204

1.31

2.68

3.3

3.2

4.1

4.4

pmol/l

3.64

142

1070

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.76

2.67

2.3

3.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

284

3396

0.82

2.65

1.2

57.2

37.4

iu/ml

1.32

1086

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.47

2.62

12.4

7.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

290

1.63

2.60

1.5

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.01

2.56

2.1

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1721

16389

1.13

2.56

5.0

3.8

21.8

13.2

mm/h

52.14

1584

15008

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

2.05

2.51

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

150

1.88

2.51

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

161

1263

1.29

2.47

1.1

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

724

1.38

2.44

1.2

0.2

1.4

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1091

11707

0.89

2.43

2.9

2.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.18

2.41

1.4

1.2

—

(3008898) HLA-B27 [Presence]

529

0.58

2.40

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.35

2.38

1.1

1917.9

1624.7

miu/ml

0.50

(21494434) Karyotype in Bone marrow

228

1.68

2.36

1.1

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.62

2.27

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.07

2.27

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

209

1.68

2.23

3.1

4.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.20

2.21

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.78

2.20

2.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

141

1106

1.29

2.20

5.6

3.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

288

1.57

2.19

2.0

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.34

2.18

1.3

1.1

184.0

167.9

ng/l

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.34

2.18

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.34

2.18

1.1

1.3

—

(3019977) pH of Arterial blood

115

1.92

2.15

3.6

2.2

7.4

—

(3017732) Neutrophils [#/volume] in Blood

173

1397

1.25

2.14

5.3

3.3

3.9

4.0

e9/l

0.13

143

1054

(3002619) Bacteria identified in Specimen by Culture

2.71

2.10

1.5

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

276

1.57

2.09

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

237

1.61

2.07

1.6

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.01

2.04

1.3

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.41

2.02

11.4

7.5

—

(3017569) Oxygen content in Arterial blood

111

1.90

2.00

2.0

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

314

1.51

1.93

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.12

1.92

1.1

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

172

0.41

1.90

1.9

2.0

6.3

3.5

ug/l

—

150

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

181

1.66

1.88

1.1

1.3

28.5

35.3

u/l

0.61

146

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.86

1.86

1.1

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.98

1.85

1.5

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

167

1.68

1.84

1.3

1.4

35.6

17.3

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.51

1.83

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

4.17

1.82

19.8

6.9

161.6

102.5

g/mol

—

(3034426) Prothrombin time (PT)

2.13

1.82

1.6

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

108

1.86

1.81

10.9

14.3

—

(3025577) Chromium [Mass/volume] in Blood

169

0.41

1.77

1.9

2.1

3.1

2.1

ug/l

—

143

(3050129) First trimester maternal screen panel - Serum or Plasma

136

0.37

1.75

1.2

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

556

0.66

1.75

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

117

1.80

1.74

1.3

1.9

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.92

1.72

1.1

1.2

99.3

101.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

267

1.51

1.68

5.1

4.7

7.8

7.3

mmol/l

0.33

229

(40757373) Influenza virus identified in Isolate

2.39

1.67

1.6

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

228

1.54

1.65

1.6

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

1916

18564

1.10

1.63

55.6

16.2

15.5

13.8

219.66

1882

18081

(40768795) Lymph node Pathology biopsy report

229

1.54

1.62

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.87

1.60

1.4

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

145

1.66

1.54

2.0

1.7

—

(3016879) Cocaine [Presence] in Urine

283

1.46

1.50

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

125

0.40

1.49

5.6

6.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.44

1.48

1.3

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.37

1.45

1.2

2.4

—

(3045424) Erythrocytes [Presence] in Urine

346

1.39

1.41

1.9

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.25

1.40

2.0

1.8

—

(3000012) Reticulocyte production index

126

1.67

1.40

2.0

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.18

1.40

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

178

0.50

1.39

1.0

69.2

43.0

ng/l

—

114

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

178

0.50

1.39

1.0

494.9

316.7

ng/l

—

118

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.08

1.38

2.5

2.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.20

1.37

1.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

502

4598

1.11

1.36

5.2

3.9

1.0

kg/l

1.02

686

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.94

1.36

1.2

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.10

1.30

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.36

1.29

1.6

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.78

1.28

1.4

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

133

0.45

1.28

1.0

1.2

—

0.8

u/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

260

1.43

1.27

1.6

1.3

0.2

0.4

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

312

1.38

1.24

1.9

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

505

1.29

1.21

1.3

1.2

2.2

5.2

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

400

1.33

1.20

1.3

1.4

15.4

9.7

u/l

1.88

314

(3028300) Cannabinoids [Presence] in Urine

314

1.38

1.20

1.9

1.8

—

(4024509)

226

0.57

1.20

1.8

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

101

1.69

1.19

1.3

1.2

1.1

ratio

—

(3023419) Bacteria identified in Sputum by Culture

272

1.40

1.19

1.7

2.5

—

(3027944) Amphetamines [Presence] in Urine

306

1.38

1.19

1.9

1.7

—

(3011985) Renin [Units/volume] in Plasma

256

1.41

1.17

1.2

1.4

181.5

53.9

mu/l

0.74

223

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

182

1.49

1.15

1.2

1.5

0.2

0.3

nmol/l

1.88

135

(3032057) Clostridioides difficile [Presence] in Stool

2.05

1.15

1.6

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

501

1.28

1.14

1.3

1.2

2.1

8.9

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.00

1.12

11.9

7.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

234

1.42

1.10

1.5

1.3

—

nmol/l

—

(3027008) Opiates [Presence] in Urine

311

1.36

1.10

1.9

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

243

1.40

1.09

1.2

1.4

574.8

289.9

pmol/l

1.47

190

(3026389) Candida sp identified in Specimen by Organism specific culture

253

1.39

1.06

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.27

1.03

30.8

14.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.84

1.02

1.1

—

(3045414) Leukocytes [Presence] in Urine

107

900

1.20

1.02

2.4

1.8

—

(3044941) Cell count panel - Synovial fluid

359

1.31

1.02

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

101

1200

0.84

1.01

1.2

173.4

135.0

iu/ml

0.21

437

(3021788) Differential panel - Synovial fluid

387

1.30

0.99

1.6

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.85

0.96

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

101

1.59

0.93

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

427

1.27

0.93

1.2

—

7.9

—

(3004616) Nuclear Ab [Presence] in Serum

235

1.37

0.91

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.63

0.90

1.1

—

11.3

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

101

0.49

0.89

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.61

0.87

1.2

1.4

6.1

8.4

ug/l

0.52

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.00

0.87

5.2

1.6

—

(3003338) MCHC [Mass/volume]

1830

18691

0.94

0.86

58.4

17.3

329.2

331.9

g/l

23.69

1799

18545

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

233

2568

0.90

0.84

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1970

20065

0.94

0.83

48.0

14.5

34.7

39.5

82.71

1336

13614

(3000034) Microalbumin [Mass/volume] in Urine

223

1.35

0.81

3.5

3.1

51.6

36.9

mg/l

0.31

168

(3023103) Potassium [Moles/volume] in Serum or Plasma

2347

23756

0.92

0.81

54.5

15.4

4.0

mmol/l

7.00

2295

23072

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

207

1.36

0.79

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

139

1.44

0.79

1.2

1.1

—

titre

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.78

0.0

1.2

—

51.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.62

0.78

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

222

0.67

0.77

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.70

0.75

1.4

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.09

0.74

2.6

2.8

0.8

0.5

u/field

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.84

0.73

1.1

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

207

0.67

0.72

1.1

1.5

—

(3022621) pH of Urine by Test strip

156

1396

1.12

0.72

3.3

2.8

—

(40758292) HTLV I+II Ab panel - Serum

1.92

0.70

1.0

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

239

1.30

0.69

1.5

75.4

60.8

1.58

142

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

178

1.35

0.68

2.3

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.56

0.68

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.60

0.68

2.1

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

798

1.16

0.68

1.5

1.4

—

(3048879) Bone marrow aspiration report

1.62

0.65

1.2

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

277

2978

0.92

0.63

17.4

6.6

—

(3014051) Protein [Presence] in Urine by Test strip

461

1.20

0.62

2.8

2.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.63

0.62

1.3

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

2.2

—

1.6

—

(40765096) Chromosome analysis panel by Banding

1.50

0.59

1.3

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

2.0

—

19.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

291

1.24

0.58

1.5

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

604

1.16

0.58

1.4

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

114

0.61

0.58

1.1

1.9

—

11.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

115

0.61

0.57

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

229

0.74

0.55

1.1

0.6

3.8

u/ml

—

111

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

203

1.28

0.55

1.5

1.4

28.0

30.4

0.14

119

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

117

1.37

0.52

2.7

4.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2347

23676

0.94

0.51

54.3

15.3

137.3

139.8

mmol/l

188.43

2298

23041

(3008401) Mugwort IgE Ab [Units/volume] in Serum

224

0.76

0.49

1.1

0.5

1.7

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.52

0.48

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

296

2801

1.06

0.45

1.3

1.4

—

(4015189)

1.37

0.44

1.3

2.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

501

0.86

0.43

1.4

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.64

0.42

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

488

0.86

0.41

1.8

1.7

3.3

4.7

iu/l

0.88

160

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

24.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

604

0.88

0.41

1.5

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

259

0.81

0.39

1.0

1.1

0.7

1.2

u/ml

0.59

103

(3023430) Cat dander IgE Ab [Units/volume] in Serum

148

0.74

0.38

1.1

1.0

1.5

2.9

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

863

0.90

0.38

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

197

1.22

0.37

1.8

2.0

1.4

2.2

u/field

0.62

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.33

0.37

1.6

1.3

3.2

1.4

—

(3022689) Creatine [Moles/volume] in Urine

1.31

0.37

2.1

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

518

1.12

0.34

5.1

3.2

38.1

26.9

mg/l

1.25

333

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

794

0.90

0.34

1.4

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

368

1.14

0.33

1.6

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.68

0.33

1.3

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

198

0.81

0.32

1.1

2.3

2.1

u/ml

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

431

0.88

0.30

1.6

1.2

4.1

3.9

mmol/l

0.40

405

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

241

1.16

0.29

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

195

1.18

0.28

1.0

1.2

319.4

365.7

nmol/l

0.59

169

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.27

0.27

1.6

2.4

1.2

ug/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

522

0.90

0.27

1.4

34.0

32.5

iu/l

0.12

433

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

150

1.20

0.26

1.2

1.1

—

5.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

142

1.20

0.24

1.2

1.3

—

50.9

—

(3035933) Granulocytes/100 leukocytes in Blood

1.28

0.23

2.4

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

228

1.14

0.22

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

228

1.14

0.22

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

228

1.14

0.22

1.3

1.2

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

9.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(4146454)

269

1.12

0.19

2.9

2.8

—

(3020650) Glucose [Presence] in Urine

1.20

0.19

1.2

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

193

1.14

0.19

1.6

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

133

0.83

0.19

3.5

2.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.19

1.0

—

(3000492) Spirometry study

197

1900

1.04

0.19

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.15

0.19

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

104

1091

0.95

0.17

1.4

1.2

562.6

230.7

u/ml

0.49

1000

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.71

0.16

1.0

—

4.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.13

0.16

1.4

1.9

18.3

18.4

ug/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

442

0.93

0.15

1.8

1.5

35.7

1727.1

e6/l

1.92

360

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.77

0.15

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

161

0.87

0.15

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

441

0.93

0.15

1.7

1.4

3.2

36.1

e6/l

1.68

341

(3000475) Leukocytes [#/volume] in Synovial fluid

539

1.06

0.13

1.6

14209.5

13388.6

e6/l

0.07

370

(44813793)

114

1.14

0.11

1.4

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

—

(3025130) Human papilloma virus identified in Specimen

203

1.08

0.09

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

311

1.06

0.09

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.11

0.09

1.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

165

1.09

0.08

1.2

1.1

—

89.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.86

0.07

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.12

0.07

1.1

—

(3015183) Erythrocyte sedimentation rate

0.86

0.07

1.4

1.2

—

(40768443) Skin Pathology biopsy report

100

976

1.03

0.07

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

105

0.86

0.06

1.3

1.5

—

(3024263) Appearance of Synovial fluid

148

1.08

0.06

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

111

0.90

0.06

1.0

—

(4027681)

1.10

0.04

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

439

1.03

0.03

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

281

1.03

0.02

2.3

2.1

23.7

23.3

mg/l

—

(40768793) Breast Pathology biopsy report

550

0.98

0.02

1.2

1.3

—

(4211845)

113

1.06

0.01

1.6

3.2

—

(4034850)

759

0.99

0.01

19.1

9.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

183

1.04

0.01

1.9

1.7

4.8

4.3

mg/l

0.26

178

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

898

0.99

0.01

1.4

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

394

1.02

0.00

1.8

1.4

—

(3006462) Nitrate [Presence] in Urine

105

1.05

0.00

1.6

3.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

445

1.01

0.00

1.4

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

142

0.99

0.00

2.4

1.7

—

(3044889) 12 lead EKG panel

1649

16493

1.00

0.00

4.8

3.8

—

(3023410) Appearance of Cerebral spinal fluid

187

1.02

0.00

1.7

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

210

1.00

0.00

1.3

216223.8

65869.6

e6/l

0.32

141

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

1.9

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.99

0.00

2.0

1.8

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(44806420)

0.94

0.00

1.7

2.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.90

0.00

2.4

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.88

0.00

3.3

2.4

183.2

158.5

nmol/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ASCITES – Ascites

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ascites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Ascites (R18_ASCITES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints